SLSarah C. R. Lummis

Sarah C. R. Lummis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sarah C. R. Lummis has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Anaesthetic Impairment of Immune Function Is Mediated via GABAA Receptors

    by Daniel W. Wheeler, Andrew J. Thompson, Federico Corletto, Jill Reckless, Justin C. T. Loke, Nicolas Lapaque, Andrew J. Grant, Pietro Mastroeni, David J. Grainger, Claire L. Padgett, et al.

    GABAA receptors are members of the Cys-loop family of neurotransmitter receptors, proteins which are responsible for fast synaptic transmission, and are the site of action of wide range of drugs [1]. Recent work has shown that Cys-loop receptors are present on immune cells, but their physiological roles and the effects of drugs that modify their function in the innate immune system are currently unclear [2]. We are interested in how and why anaesthetics increase infections in intensive care patients; a serious problem as more than 50% of patients with severe sepsis will die [3]–[6]. As many anaesthetics act via GABAA receptors [7], the aim of this study was to determine if these receptors are present on immune cells, and could play a role in immunocompromising patients. We demonstrate, using RT-PCR, that monocytes express GABAA receptors constructed of α1, α4, β2, γ1 and/or δ subunits. Whole cell patch clamp electrophysiological studies show that GABA can activate these receptors, resulting in the opening of a chloride-selective channel; activation is inhibited by the GABAA receptor antagonists bicuculline and picrotoxin, but not enhanced by the positive modulator diazepam. The anaesthetic drugs propofol and thiopental, which can act via GABAA receptors, impaired monocyte function in classic immunological chemotaxis and phagocytosis assays, an effect reversed by bicuculline and picrotoxin. Our results show that functional GABAA receptors are present on monocytes with properties similar to CNS GABAA receptors. The functional data provide a possible explanation as to why chronic propofol and thiopental administration can increase the risk of infection in critically ill patients: their action on GABAA receptors inhibits normal monocyte behaviour. The data also suggest a potential solution: monocyte GABAA receptors are insensitive to diazepam, thus the use of benzodiazepines as an alternative anesthetising agent may be advantageous where infection is a life threatening problem.


  • Characterization of 5-HT3 Receptor Mutations Identified in Schizophrenic Patients

    by Andrew J. Thompson, Nora L. Sullivan, Sarah C. R. Lummis

    The 5-HT3receptor is a member of the Cys-loop family of ligand-gated ion channels, proteins that have been implicated in the pathology of several neurological disorders. In this study, we examine...


  • Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT 3 receptor

    by Nora L. Sullivan, Andrew J. Thompson, Kerry L. Price, Sarah C. R. Lummis

    The ligand binding pocket of Cys-loop receptors consists of a number of binding loops termed A–F. Here we examine the 5-HT3 receptor loop A residues Asn-128, Glu-129 and Phe-130 using modelling, mutagenesis, radioligand binding and functional studies on HEK 293 cells. Replacement of Asn-128 results in receptors that have wild type [3H]granisetron binding characteristics but large changes (ranging from a five-fold decrease to a 1500-fold increase) in the 5-HT EC50 when compared to wild type receptors. Phe-130 mutant receptors show both increases and decreases in Kd and EC50 values, depending on the amino acid substituted. The most critical of these residues appears to be Glu-129; its replacement with a range of other amino acids results in non-binding and non-functional receptors. Lack of binding and function in some, but not all, of these receptors is due to poor membrane expression. These data suggest that Glu-129 is important primarily for receptor expression, although it may also play a role in ligand binding; Phe-130 is important for both ligand binding and receptor function, and Asn-128 plays a larger role in receptor function than ligand binding. In light of these results, we have created two new homology models of the 5-HT3 receptor, with alternative positions of loop A. In our preferred model Glu-129 and Phe-130 contribute to the binding site, while the location of Asn-128 immediately behind the binding pocket could contribute to the conformation changes that result in receptor gating. This study provides a new model of the 5-HT3 receptor binding pocket, and also highlights the importance of experimental data to support modelling studies.


  • Molecular modeling of the GABAC receptor ligand-binding domain

    by Neil J. Harrison, Sarah C.R. Lummis

    We have constructed a molecular model of the ligand-binding domain of the GABAC receptor, which is a member of the Cys-loop ligand-gated ion channel family. The extracellular domains of these receptors share similar sequence homology (20%) with Limnaea acetylcholine-binding protein for which an X-ray crystal structure is available. We used this structure as a template for homology modeling of the GABAC receptor extracellular domain using FUGUE and MODELLER software. FlexX was then used to dock GABA into the receptor ligand-binding site, resulting in three alternative energetically favorable orientations. Residues located no more than 5 Å from the docked GABA were identified for each model; of these, three were found to be common to all models with 14 others present only in certain models. Using data from experimental studies, we propose that the most likely orientation of GABA is with its amine close to Y198, and its carboxylate close to R104. These studies have therefore provided a model of the ligand-binding domain, which will be useful for both GABAC and GABAA receptor studies, and have also yielded an experimentally testable hypothesis of the location of GABA in the binding pocket. Figure GABA docked into the binding site using FlexX. Orientation 3. Residues shown are those within 5 Å of GABA. H-bonds are shown as green dashed lines


  • Open Access

    A single ring of charged amino acids at one end of the pore can control ion selectivity in the 5‐HT3 receptor

    by Andrew J Thompson, Sarah C R Lummis

    To determine the mechanisms by which cation‐ or anion‐specific channels select between these ions, we have examined the role of electrostatic factors in a typical ligand‐gated ion channel, the 5‐hydroxytryptamine3 (5‐HT3) receptor, by removal and/or insertion of rings of conserved charged residues at either end of the pore. Neutralization of the negatively charged ring at the intracellular end of the channel (E−1′A) results in a nonselective channel (PNa/PCl=0.89). Insertion of positively charged residues at the extracellular end of the pore either results in a nonfunctional receptor (A24′K) or one that remains cation‐selective (PNa/PCl=110; S19′R). Combining the removal of a negatively charged ring (E−1′A) with the insertion of a positively charged ring (S19′R), however, results in a channel that is predominantly anion‐selective (PNa/PCl=0.37). The data suggest that for the cation‐selective 5‐HT3 receptor, the control of selectivity exerted by charged rings at either end of the pore is dominated by the ring of negatively charged residues at the intracellular side of the channel. As changing the charge at this position has also been shown to change ionic selectivity in anion‐selective receptors, these data suggest that electrostatic factors can control selectivity in the whole Cys‐loop family. British Journal of Pharmacology (2003) 140, 359–365. doi:10.1038/sj.bjp.0705424


  • Ion channels — a plethora of pharmaceutical targets

    by Jamie I. Vandenberg, Sarah C.R. Lummis